Ad
GG Quote Trading Chart Goldcorp Inc.
Quote | Goldcorp Inc. (NYSE:GG)
| Last: | $ |
|---|---|
| Change Percent: | 0.00% |
| Open: | $N/A |
| Close: | $11.19 |
| High: | $N/A |
| Low: | $N/A |
| Volume: | 0 |
| Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
GG Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $ | $N/A | $11.19 | $N/A | $N/A | 0 | 04-24-2019 |
| $ | $N/A | $11.19 | $N/A | $N/A | 0 | 04-23-2019 |
| $ | $N/A | $11.19 | $N/A | $N/A | 0 | 04-22-2019 |
| $ | $N/A | $11.19 | $N/A | $N/A | 0 | 04-19-2019 |
| $ | $N/A | $11.19 | $N/A | $N/A | 0 | 04-18-2019 |
| $ | $11.38 | $11.19 | $11.49 | $11.15 | 34,505,162 | 04-17-2019 |
| $ | $11.54 | $11.42 | $11.57 | $11.395 | 19,454,885 | 04-16-2019 |
| $ | $11.50 | $11.60 | $11.61 | $11.45 | 10,620,665 | 04-15-2019 |
| $ | $11.59 | $11.61 | $11.67 | $11.39 | 21,565,481 | 04-12-2019 |
| $ | $11.47 | $11.52 | $11.62 | $11.42 | 11,676,807 | 04-11-2019 |
| $ | $11.68 | $11.60 | $11.76 | $11.59 | 12,676,034 | 04-10-2019 |
| $ | $11.76 | $11.71 | $11.77 | $11.60 | 9,929,210 | 04-09-2019 |
| $ | $11.76 | $11.76 | $11.80 | $11.64 | 7,556,853 | 04-08-2019 |
| $ | $11.65 | $11.69 | $11.71 | $11.55 | 7,563,290 | 04-05-2019 |
| $ | $11.41 | $11.70 | $11.70 | $11.40 | 16,748,512 | 04-04-2019 |
| $ | $11.51 | $11.52 | $11.56 | $11.42 | 11,929,605 | 04-03-2019 |
| $ | $11.37 | $11.47 | $11.50 | $11.31 | 11,731,679 | 04-02-2019 |
| $ | $11.44 | $11.37 | $11.535 | $11.33 | 18,498,431 | 04-01-2019 |
| $ | $11.43 | $11.44 | $11.52 | $11.3704 | 14,460,442 | 03-29-2019 |
| $ | $11.20 | $11.37 | $11.48 | $11.20 | 13,125,382 | 03-28-2019 |
Stock Information
Get GG Alerts
News, Short Squeeze, Breakout and More Instantly...
Goldcorp Inc. Company Name:
GG Stock Symbol:
NYSE Market:
0.00% G/L:
$ Last:
0 Volume:
$N/A Open:
$11.19 Close:
Goldcorp Inc. Website:
Ad
Important Investor News Alert (NASDAQ: CVKD)
-
LVAD patients face a high risk of bleeding events associated with oral anticoagulation alongside increased risk of cardiovascular (CV) events such as stroke Hospitalization costs for patients following a major bleeding event associated with oral anticoagulation use averages $39,000 per ev...